Skip to main content
Clinical Trials/JPRN-UMIN000011094
JPRN-UMIN000011094
Recruiting
Phase 1

Anti-vascular endothelial growth factor therapy for ocular diseases with neovascularization - Anti-VEGF therapy for ocular neovascularization

Kobe University Graduate school of Medicine0 sites510 target enrollmentStarted: July 15, 2013Last updated:

Overview

Phase
Phase 1
Status
Recruiting
Sponsor
Kobe University Graduate school of Medicine
Enrollment
510

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
ot applicable to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)high risk of stroke or myocardial infarction 2\)systemic diseases with vessel occulusions 3\)ocular infection

Investigators

Sponsor
Kobe University Graduate school of Medicine

Similar Trials